TickerLeague

Free Cash Flow for Illumina (ILMN)

Free Cash Flow for Illumina (ILMN): headline value $939.00M · YoY +31.3%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$939.00M

YoY change

+31.3%

5Y CAGR

+0.9%

Peak year (2025)

$931.00M

Latest annual

$931.00M

Free Cash Flow history chart for Illumina (ILMN) from 1999 to 2025

Free Cash Flow history table for Illumina (ILMN) from 1999 to 2025

Fiscal yearPeriod endedReportedFree Cash FlowYoY
2025$931.00M+31.3%
2024$709.00M+151.4%
2023$282.00M+166.0%
2022$106.00M-68.5%
2021$337.00M-62.2%
2020$891.00M+5.8%
2019$842.00M-0.5%
2018$846.00M+50.3%
2017$563.00M+35.4%
2016$415.86M-19.5%
2015$516.35M+43.8%
2014$359.06M+21.4%
2013$295.86M+40.3%
2012$210.86M-24.3%
2011$278.59M+28.9%
2010$216.10M+81.2%
2009$119.27M-1627.0%
2008-$7.81M-124.5%
2007$31.87M+34.0%
2006$23.79M-216.6%
2005-$20.40M-11.0%
2004-$22.93M+13.0%
2003-$20.29M-61.3%
2002-$52.42M+102.4%
2001-$25.90M+46.0%
2000-$17.74M+453.9%
1999-$3.20M

Free Cash Flow values are taken from Illumina's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Illumina (ILMN) reported free cash flow of $931.00M – surged 31.3% year-over-year.

Illumina free cash flow compound annual growth for the 2020–2025 (5 years) window is +0.9%, sustaining 3 straight years of year-over-year growth.

Across the available history, free cash flow reached its high of $931.00M in 2025 and its low of -$52.42M in 2002.

Among 8 Healthcare peers, Illumina (ILMN) ranks 9th; the peer median for free cash flow is $14.22B.

Illumina Free Cash Flow by Year

Illumina Free Cash Flow 2025: $931.00M

Illumina free cash flow in 2025 was $931.00M, surged 31.3% from 2024. This figure represents the highest annual value in the available history.

Illumina Free Cash Flow 2024: $709.00M

Illumina free cash flow in 2024 was $709.00M, surged 151.4% from 2023.

Illumina Free Cash Flow 2023: $282.00M

Illumina free cash flow in 2023 was $282.00M, surged 166.0% from 2022.

Illumina Free Cash Flow 2022: $106.00M

Illumina free cash flow in 2022 was $106.00M, plunged 68.5% below 2021.

Illumina Free Cash Flow 2021: $337.00M

Illumina free cash flow in 2021 was $337.00M.

See more financial history for Illumina (ILMN).

Sector peers — Free Cash Flow

Companies in the same sector as Illumina, ranked by their latest free cash flow.

CompanyFree Cash FlowSector
Novo Nordisk A/S (NVO)$28.99BHealthcare
Johnson & Johnson (JNJ)$19.70BHealthcare
AbbVie Inc. (ABBV)$17.82BHealthcare
UnitedHealth Group Incorporated (UNH)$16.07BHealthcare
Merck & Co., Inc. (MRK)$12.36BHealthcare
AstraZeneca PLC (AZN)$11.77BHealthcare
Eli Lilly and Company (LLY)$8.97BHealthcare
Amgen Inc. (AMGN)$8.10BHealthcare

Frequently asked questions

What is Illumina's free cash flow?

Latest reported free cash flow for Illumina (ILMN) is $939.00M (period ending December 28, 2025).

How has Illumina free cash flow changed year-over-year?

Illumina (ILMN) free cash flow changed +31.3% year-over-year on the latest annual filing.

What is the long-term growth rate of Illumina free cash flow?

Illumina (ILMN) free cash flow compound annual growth rate is +0.9% over the most recent 5 years available.

When did Illumina free cash flow hit its highest annual value?

Illumina free cash flow reached its highest annual value of $931.00M in 2025.

What was Illumina free cash flow in 2024?

Illumina (ILMN) free cash flow in 2024 was $709.00M.

What was Illumina free cash flow in 2025?

Illumina (ILMN) free cash flow in 2025 was $931.00M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.